Navigation Links
STERIS Corporation Announces Date of Fiscal 2010 First Quarter Earnings Release and Conference Call
Date:7/20/2009

intended to qualify for the protections afforded "forward-looking statements" under the Private Securities Litigation Reform Act of 1995 and other laws and regulations. Forward-looking statements speak only as to the date of this report, and may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "targets," "forecasts," "confidence," and "seeks," or the negative of such terms or other variations on such terms or comparable terminology. Many important factors could cause actual results to differ materially from those in the forward-looking statements including, without limitation, disruption of production or supplies, changes in market conditions, political events, pending or future claims or litigation, competitive factors, technology advances, and changes in government regulations or the application or interpretation thereof. Other risk factors are described in the Company's Form 10-K and other securities filings. Many of these important factors are outside STERIS's control. No assurances can be provided as to any future financial results. Unless legally required, the Company does not undertake to update or revise any forward-looking statements even if events make clear that any projected results, express or implied, will not be realized. Other potential risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements include, without limitation, (a) the potential for increased pressure on pricing that leads to erosion of profit margins, (b) the possibility that market demand will not develop for new technologies, products or applications, or the Company's business initiatives will take longer, cost more or produce lower benefits than anticipated, (c) the possibility that application of or compliance with laws, court rulings, regulations, certifications or other requirements or standards may delay or prevent new prod
'/>"/>
SOURCE STERIS Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
2. STERIS Corporation Announces Date of Fiscal 2008 Second Quarter Earnings Release and Conference Call
3. STERIS Corporation Announces Fiscal 2008 Second Quarter Results
4. STERIS Corporation Announces Date of Fiscal 2008 Third Quarter Earnings Release and Conference Call
5. STERIS Corporation Declares Regular Quarterly Dividend
6. STERIS Corporation Announces Fiscal 2008 Third Quarter Results
7. STERIS Corporation Promotes Timothy L. Chapman to Group President of Healthcare
8. STERIS Corporation Announces New $300 Million Share Repurchase Authorization
9. STERIS Corporation Names Michael J. Tokich Chief Financial Officer
10. STERIS Corporation Declares Regular Quarterly Dividend
11. Steris Corporation Announces the Appointment of Two New Directors

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)...USNewswire/ -- A regional initiative launched in t...ess) in the Americas has substantially reduced the...denced by a 31% decrease in the number of individu...mic countries. Results were reported today at the...opical Medicine and Hygiene (ASTMH). ,, The re...
(Date:11/21/2009)...edentialing software company IntelliSoft Group is ...th Amerinet, Inc., the leading healthcare G.P.O. i...m quality care within the healthcare market. , ... ISG Group, LLC, doing business as IntelliSoft Gro...c., a leading national healthcare group purchasing...
(Date:11/21/2009)...dent and chief executive officer of the Alzheimer,... statement regarding the inclusion of cognitive im...ess for Medicare beneficiaries in "The Patien...s introduced last night: , .... Hall, president and chief executive officer of t...
(Date:11/20/2009)...nderstanding Brain Wiring and Diseases ,, WASHI...my Schmahmann, Professor of Neurology at Harvard M... General Hospital in Boston, on Thursday, November...w field of study called "Connectivity" at the laun...n is an award-winning leader in the field of the c...
(Date:11/20/2009)...re-USNewswire/ -- The United States Conference of ...l changes its health reform bill in order to keep ...ience protection on abortion, protect access to he...ions for adequate affordability. ,, The bishops...isappointment" that creates new and unacceptable f...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:MINDlink Foundation Launches to Connect the Cerebellum to Cures 2Health News:U.S. Bishops Voice Disappointment in Abortion-Funding Provisions in Senate Health Bill, Urge Better Care for Immigrants and Affordability 2
...dietary habits and increased weight in the middle ... of high calorie diet and employment of food as mo...the students//. Other factors such as selling food...hildren population are burdened with this curse of...
...HIV positive people of Mizo society to treat them ...eath. Malsawmdawnga who is the president of Mizora... press talk stating that even as the world is chan...ad bodies of AIDS patients in polytene bags before...
...ai spoke to the press about improvising the health...aid that the city needs more hospitals with ICUs//...ices, which are easily accessible by the public. ...inister Mr. Nitish Kumar is also having a keen int...
...ed for curtailing comparative advertisements, afte...ucers//. Suitable amendments should be made to the...n addition to other media and channels, and the Mo...roducts of a competitor are concerned. Comparative...
...pal gas leak tragedy was on Saturday 30 doctors of...resigned. The doctors wanted a pay hike. The...treatment daily. Run by a trust, the BMHRC was set...aintenance Act (ESMA) has been imposed on the juni...
...st bird flu to all its poultry birds and wild bird...ess program to farmers and villagers about the imp... the villagers to report immediately any doubtful ...lu and is an increased threat for mutation of the ...
Other Medicine News:Health News:Conditions Of The HIV/AIDS Patients In The Mizo Society 2
(Date:11/20/2009)..., , FRANKLIN LAKES, N.J., Nov. 20 /PRNewswi...) (NYSE: BDX ) today announced the completion of...Michigan-based company that develops and manufactu...tforms. ,, In May 2009, BD and HandyLab announc...mmercialize molecular assays on the HandyLab Jagua...
(Date:11/20/2009)..., , PRINCETON, N.J., Nov. 20 /PRNewswire-... SNGX) (Soligenix or the Company), formerly known ... company, announced today that it has formed a con...nce RiVax(TM) and other rapidly acting vaccines. S...tional Institute of Allergy and Infectious Disease...
(Date:11/19/2009)..., , BIRMINGHAM, Ala., Nov. 19 /PRNewswire...daq: BCRX ) today announced the pricing of a publ...k at $9.75 per share, resulting in gross proceeds ...fered by BioCryst pursuant to an effective shelf r...curities and Exchange Commission. BioCryst has al...
Breaking Medicine Technology:BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3WuXi PharmaTech Announces Second Quarter 2009 Results 13509 1WuXi PharmaTech Announces Second Quarter 2009 Results 13509 2WuXi PharmaTech Announces Second Quarter 2009 Results 13509 3WuXi PharmaTech Announces Second Quarter 2009 Results 13509 4WuXi PharmaTech Announces Second Quarter 2009 Results 13509 5WuXi PharmaTech Announces Second Quarter 2009 Results 13509 6WuXi PharmaTech Announces Second Quarter 2009 Results 13509 7WuXi PharmaTech Announces Second Quarter 2009 Results 13509 8WuXi PharmaTech Announces Second Quarter 2009 Results 13509 9WuXi PharmaTech Announces Second Quarter 2009 Results 13509 10WuXi PharmaTech Announces Second Quarter 2009 Results 13509 11WuXi PharmaTech Announces Second Quarter 2009 Results 13509 12WuXi PharmaTech Announces Second Quarter 2009 Results 13509 13WuXi PharmaTech Announces Second Quarter 2009 Results 13509 14WuXi PharmaTech Announces Second Quarter 2009 Results 13509 15WuXi PharmaTech Announces Second Quarter 2009 Results 13509 16VIVUS Reports Second Quarter 2009 Financial Results 54258 1VIVUS Reports Second Quarter 2009 Financial Results 54258 2VIVUS Reports Second Quarter 2009 Financial Results 54258 3VIVUS Reports Second Quarter 2009 Financial Results 54258 4VIVUS Reports Second Quarter 2009 Financial Results 54258 5VIVUS Reports Second Quarter 2009 Financial Results 54258 6VIVUS Reports Second Quarter 2009 Financial Results 54258 7Mesa Labs Reports Higher First Quarter Earnings 54256 1Mesa Labs Reports Higher First Quarter Earnings 54256 2Mesa Labs Reports Higher First Quarter Earnings 54256 3Mesa Labs Reports Higher First Quarter Earnings 54256 4Mesa Labs Reports Higher First Quarter Earnings 54256 5
...ebruary 26 ExonHit Therapeutics,(Alternext: ALEHT...EHT 0202,its lead compound in Alzheimer,s disease,...ase IIa trial assessing EHT 0202 in patients with,...ssful completion of patient enrolment for the Phas...elopment of EHT 0202, and,provides a clear timelin...
...cians at Northwestern Memorial are among the first...al natural orifice translumenal endoscopic surgery...thwestern Memorial Hospital successfully removed a...them the first in the Midwest and the third in the...technique, known as NOTES -- natural orifice trans...
Other Medicine Technology:ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 2ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 3ExonHit Therapeutics Reports Advancements in the Clinical Development of EHT 0202, its Phase II Drug for Alzheimer's Disease 4Gallbladder Removal Through Vagina Offers Minimally Invasive Alternative 2Gallbladder Removal Through Vagina Offers Minimally Invasive Alternative 3
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
...a national reference laboratory and a worldwide le...ment. ARUP offers an extensive test menu of highly...anatomic pathology. Owned by the University of Uta...lf of the nation's university teaching hospitals a...
Medicine Products: